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Abstract
Background. Studies demonstrate an inverse relationship between institution/surgeon procedural volumes and patient
outcomes. Similar studies exist for liver resections, which recommend referral of patients for liver resections to ‘high-volume’
centers. These studies did not elucidate the factors that underlie such outcomes. We believe there exists a complex interaction
of patient-related and perioperative factors that determine patient outcomes after liver resection. We sought to delineate these
factors.
Methods. Retrospective review of 114 liver resections by a single surgeon from 1993–2003: Records were reviewed for
demographics; diagnosis; type/year of surgery; American Society of Anesthesiologists (ASA) score; preoperative albumin,
creatinine, and bilirubin; operative time; intraoperative blood transfusions; epidural use; and intraoperative hypotension.
Main outcome measurements were postoperative morbidities, mortalities and length of stay (LOS). Data were analyzed using
a multivariate linear regression model (SPSS v10.1 statistical analysis program).
Results. Primary indications for resections were hepatocellular carcinoma (HCC) (N=57), metastatic colorectal cancer
(N=25), and benign disease (N=18). There were no intraoperative mortalities and 4 perioperative (30-day) mortalities
(3.5%). Mortality occurred in patients with malignancies who were older than 50 years. Morbidity was higher in malignant
(15.6%) versus benign (5.5%) disease. Complications included bile leak/stricture (N=6), liver insufficiency (N=3), post-
operative bleeding (N=2), myocardial infarction (N=2), aspiration pneumonia (N=1), renal insufficiency (N=1), and
cancer implantation into the wound (N=1). Average LOS for all resections was 8.6 days. Longer operative time (p=0.04),
lower albumin (p50.001), higher ASA score (p50.001), no epidural use (p=0.04), and higher creatinine (p50.001) all
correlated positively with longer LOS. ASA score and creatinine were the strongest predictors of LOS. LOS was not affected
by patient age, sex, diagnosis, presence of malignancy, intraoperative transfusion requirements, intraoperative hypotension,
preoperative bilirubin, case volume per year or year of surgery.
Conclusions. Liver resections can be performed with low mortality/morbidity and with acceptable LOS by an experienced liver
surgeon. Outcome as measured by LOS is most influenced by patient comorbidities entering into surgery. Annual case volume
did not influence LOS and had no impact on patient safety. Length of stay may not reflect surgeon/institution performance, as
LOS is multifactorial and likely related to patient population, patient selection and increased high-risk cases with a surgeon’s
experience.
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Introduction
Numerous studies have shown an inverse relationship
between the procedural volumes of an institution or
individual surgeon and patient outcomes [1–6]. This
relationship has been most consistent for more
complex procedures, such has coronary artery bypass
grafting, carotid endarterectomy, esophagectomy, and
pancreatectomy [2–5]. Similar studies exist for liver
resections which advocate referral of patients for liver
resections to centers that perform more than 10–17
liver resections per year [6–9]. These studies did not
clearly elucidate the factors that underlie such
improved outcomes. We believe that institution or
surgeon volume alone are not the sole determinants of
patient outcomes after liver resection, as there is likely a
more complex interaction of factors that have yet to be
defined. We examined 114 liver resections done, over a
ten-year period, by a single liver surgeon to address
which factors are most predictive of patient outcome as
measured by mortality, morbidity and length of stay
(LOS) after liver resection.
Methods
We retrospectively examined 114 liver resections done
by a single liver surgeon over a ten-year period, 1993–
2003. All cases, with the exception of 5 (4.4%), were
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done at a single institution, which is a tertiary referral
center and teaching affiliate of the University of Hawaii
School of Medicine. This institution also has the only
liver transplant program and liver disease center in the
State and is the sole referral center for liver disease for
the American territories of the Pacific Basin. Other
complex procedures such as open-heart surgery,
vascular surgery, neurosurgery, and endocrine surgery
are routinely performed at this institution.
The cohort consisted of 67 males and 47 females.
Patients ranged in age from 1–85 years with a mean age
of 57 years. Eighteen underwent resection for benign
processes, including 5 for focal nodular hyperplasia, 4
for hemangioma, 3 for biliary cystadenomas, and 2 for
stones/strictures. Ninety-six underwent resection for
malignancies, including 57 for HCC, 25 for metastatic
colorectal cancer, and 6 for cholangiocarcinoma.
Patients were deemed operable if the resection was
anatomically possible and had a Child-Turcotte-Pugh
score equal to or less than 7, without significant ascites
or encephalopathy. A total of 43 right lobectomies, 36
wedge resections, 19 left lateral segmentectomies, 11
left lobectomies, 3 trisegmentectomies, 1 resection of
segments 7 and 8, and 1 caudate resection were
performed.
Charts were reviewed for patient demographics,
diagnosis, type of resection and year of surgery. Pre-
operative patient-related factors noted included serum
albumin, creatinine and bilirubin. Intraoperative
factors were recorded, including ASA score, operative
time, packed red blood cell transfusion require-
ments, epidural use, and intraoperative hypotension
episodes (SBP590). Main outcome measures were
postoperative morbidities, mortalities and LOS.
Length of stay was defined as the period from the date
of surgery to the date of discharge (or expiration in the
hospital).
Data were analyzed using a multivariate linear
regression model using the SPSS v10.1 statistical
analysis program.
Results
There were 114 liver resections performed over a ten-
year period. Table I summarizes the patient-related
and intraoperative factors reviewed. The average LOS
was 8.6 days with a range of 5–35 days. A longer LOS
was significantly correlated with a lower preoperative
albumin (p50.001), higher creatinine (p50.001),
higher ASA score (p50.001), longer operative time
(p=0.04), and the lack of an intra/perioperative
epidural (p=0.04). Length of stay was not significantly
affected by patient age, sex, diagnosis, presence of
malignancy, intraoperative transfusion requirements,
intraoperative hypotension episodes, preoperative
bilirubin, case volume per year or year of surgery.
Linear regression modeling revealed that ASA score
and creatinine were the strongest predictors of longer
LOS. For every increase of 1 mg/dL in creatinine, LOS
increased by 4.4 days. For every increase in ASA score
of 1, LOS increased by 1.5 days.
There were no intraoperative mortalities. There
were 4 postoperative deaths resulting in a 30-day
perioperative mortality rate of 3.5%. All mortalities
occurred in patients being treated for malignancies and
who were more than 50 years old. Two patients died
from myocardial infarction, one patient died from
aspiration pneumonia and one died from postoperative
hemorrhage.
Overall there were 16 postoperative complications.
Morbidity was higher in malignant (15.6%) than in
benign (5.5%) disease. Complications included: bile
leak or stricture, 6; liver insufficiency, 3; bleeding
requiring re-operation, 2; myocardial infarction, 2; and
aspiration pneumonia, renal insufficiency, and cancer
implantation into the wound, 1 each.
Discussion
Multiple studies, reviewing primarily administrative
databases, show an inverse relationship between insti-
tution/surgeon volumes and patient outcomes [1–6].
These relationships are most striking in complex
cases including liver resections. Choti et al. reviewed
data from 606 liver resections from 52 non-federal
acute-care hospitals in Maryland from 1990 to 1996
[7]. He demonstrated a 7.9% mortality rate at centers
that performed less than 15 liver resections per year
compared with 1.5% for centers that performed more
than 15 resections per year. Glasgow et al. studied
Table I. Preoperative patient-related and intraoperative factors and effect on LOS
Mean Range Effect on LOS
Preoperative serum albumin* 3.8 g/dl 1.7–4.6 g/dl lower albumin increased LOS
Preoperative bilirubin 0.95 mg/dl 0.2–8.4 mg/dl no effect
Preoperative creatinine*# 0.9 mg/dl 0.4–3.6 mg/dl higher creatinine increased LOS
ASA score*# 2.3 1–4 higher ASA increased LOS
Intraoperative blood transfusion 2.8 units 0–18 units no effect
Operative time* 276 min 80–555 min longer operative time increased LOS
Intraoperative hypotension (SBP590) per patient 0.3 episodes 0–8 episodes no effect
Epidural use* 67.7% of cases no epidural increased LOS
* p50.05.
# strongest predictors of LOS.
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discharge abstracts from 507 liver resections from 138
California hospitals done between 1990 and 1994 [8].
He demonstrated similar volume-outcome relation-
ships showing a mortality rate of 6.2% for institutions
performing more than 17 liver resections per year.
Hospitals performing 16 or less resections per year had
a mortality rate ranging from 14.7% to 24.4%. Dimick
et al. reviewed the National Inpatient Sample between
1996 and 1997 and, from 2097 liver resections, found
an overall mortality rate of 5.8% [9]. The National
Inpatient Sample includes a 20% stratified random
sample of all US hospital discharges. Dimick’s study
group comprised 221 hospitals from 19 states in 1996,
and 251 hospitals from 22 states in 1997. High-volume
centers (410 resections/year) had a significantly lower
mortality rate of 3.9% versus 7.6% for low-volume
centers, which performed 9 or less liver resections
annually. Although we performed a mean of 11 resec-
tions annually over the ten-year study period and may
therefore be considered a ‘low-volume’ center by many
of these studies, our mortality was 3.5%. This was
comparable to that achieved at ‘high-volume’ centers.
Single-surgeon series of liver resections have been
reported in the literature (Table II). Factors that were
reported to influence morbidity include preoperative
bilirubin, extent of resection, degree of blood loss, and
operative time [10]. Additionally, Shiu et al. noted that
Child-Pugh class significantly influenced the rate of
complications and LOS [12]. These single-surgeon
studies demonstrate that providers who would other-
wise be categorized as low-volume providers based on
prevailing literature can achieve low and acceptable
mortality and morbidity rates.
The role of surgeon experience has also been
addressed in several studies. Lieberman et al. looked at
patients undergoing pancreatectomy for malignancy
and suggested that an institution’s volume had a
greater role in patient outcome than the annual volume
of individual surgeons [3]. This was also concluded by
Harmon and colleagues who looked at surgeon
experience in colorectal procedures and found that
low-volume surgeons practicing in high-volume
centers have similar outcomes as their high-volume
counterparts operating at the same center [15]. These
studies suggest that an institution’s practices can
compensate for surgeon experience. This has not been
substantiated in the context of liver resections. There is
a persisting clinical impression that the practices
adopted by an institution are greatly influenced by
surgeon experience and preference—to what extent,
however, is difficult to measure. With time, a senior
surgeon’s influence may become ingrained in the
institution’s practice. As a result, nursing and ancillary
care practices may then carry over to the care of other
surgeons’ patients. This may partially explain how
an institution can ‘compensate’ for an individual
surgeon’s case volume and experience.
At our medical center, which performs the most liver
resections in the State along with all liver transplants,
the operating rooms are staffed with knowledgeable
individuals and have the technology necessary for
successful major liver operations. Patients also receive
their postoperative care in the same intensive care unit
or on one particular ward in the hospital. Staff in these
dedicated areas are educated frequently by both
physicians and liver transplant coordinators and the
nursing practices in these two units are thus more
focused on the postoperative care of these patients.
Despite uniform institution-specific factors for
patients at our center, there were still notable differ-
ences in outcomes. Patient age may have been a factor,
as mortalities occurred only in patients more than 50
years old. All morbidities also occurred in patients
older than 50, with the exception a 43-year-old patient
who had cancer implanted into the surgical wound,
and a 48-year-old who had postoperative liver insuffi-
ciency. All mortalities and a majority of morbidities
occurred in patients who were being treated for
malignancy. This suggests that other factors are
involved in patient outcome independent of institu-
tional or surgeon case volume. Our study, however, is
limited by a small patient sample size with a small
number of mortalities and morbidities and therefore
lacked the statistical power necessary to elucidate these
differences.
With regard to LOS, patients with a greater ASA
score and a higher creatinine were more likely to have
longer hospital stays. Since ASA score indicates a
patient’s anesthetic risk based on pre-existing comor-
bidities, it is intuitive that patients with a higher ASA
score would be at greater risk for perioperative
complications that could delay discharge. Similar
studies have shown ASA score to correlate positively
with greater postoperative morbidity rates [10,16–17]
Preoperative hypoalbuminemia was also a significant
prognosticator for LOS in our study, but to a lesser
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extent. These findings suggest that the most significant
determinants of hospital stay may be a patient’s
condition entering into surgery.
There may be other factors that influence LOS but
there is no consensus. In the population Dimick
studied, median length of stay was 7 days [9]. High-
volume centers overall had a LOS one day shorter than
low-volume centers. Length of stay was most influ-
enced by age greater than 65, urgent/emergent
admission, female gender, malignancy, metastatic
disease, chronic pulmonary disease and severe liver
disease. Length of stay, although a useful indicator of
overall financial savings to third party payers, may not
reflect accurately the quality of care provided by a
surgeon or institution. The determinants that affect
LOS are multifactorial and may in fact be specific to
the patient population served. In comparison to other
centers, our center had a higher proportion of patients
with HCC. Although not statistically significant, there
was a trend towards longer LOS for patients with
HCC. We also saw a significant correlation between
the intra/perioperative use of epidural analgesia and
shorter hospital stays. Epidurals may help in timely
discharge due to improved pain control, better mobility
and decreased postoperative ileus [18]. As in other
studies, we also noted longer operative times were
significantly correlated with longer hospital stays
[10,16].
Studies that show such volume-outcome relation-
ships have prompted organizations like the Leapfrog
Group to recommend the referral of patients to centers
that fulfill an annual case volume criterion set by the
group [19]. The Leapfrog Group is comprised of
Fortune 500 companies that provide healthcare
insurance for about 24 million employees, spending
about 45 billion dollars annually. They hope to use
their economic influence to improve patient safety.
The Leapfrog Group has set criteria as to which insti-
tutions are eligible to provide care to their employees
based on annual case volume in the areas of coronary
artery bypass grafting, coronary angioplasty, carotid
endarterectomy, abdominal aortic aneurysm repair,
and esophageal cancer surgery. Similar patient advo-
cacy groups and commercial endeavors that provide
consumers with institution ratings or ‘grades’ are
increasing and advocating the referral of patients to
high-volume centers for other procedures. With more
studies showing volume-outcome relationships for
other complex procedures it is inevitable that similar
initiatives will be set for liver resection.
Although annual hospital volume is an easy bench-
mark to follow, it may not be a true indication reflective
of quality care. There are institutions that may not
meet a set annual volume criterion, but still provide
excellent quality of care with good patient outcomes.
These centers may be eliminated with initiatives such
as the Leapfrog Group. Despite the demonstrated
volume-outcome relationships there are also no
universally accepted annual volume ‘cutoff’ that would
qualify a center or surgeon as a ‘high-volume’ provider.
There are clearly centers that may not meet the volume
criteria set by some of these studies, but nevertheless
provide acceptable mortality and morbidity rates and
achieve other nationally accepted benchmarks of
quality and excellence, such as LOS. As our own series
illustrates, there are factors other than volume alone
that must be taken into consideration before imple-
menting mandates as to which institutions or surgeons
are deemed safe to conduct liver resections.
Conclusion
Liver resections can be performed with low mortality
and morbidity and with acceptable LOS by an
experienced liver surgeon; however, outcome based on
this matrix is most influenced by patient comorbidities
entering into surgery. The strongest predictors of
outcome were creatinine and ASA score. Preoperative
albumin also influenced LOS but to a lesser degree.
The use of epidural anesthesia intraoperatively and
measures to decrease operative time may also help in
reducing LOS. Annual case volume did not influence
LOS and had no impact on patient safety. Length of
stay may not reflect a surgeon’s or institution’s
performance, as LOS is multifactorial and more likely
related to patient population variable, patient selection
and increased high-risk cases with a surgeon’s cumu-
lative experience.
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